University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Using Rheological Methods to Characterize Cystic Fibrosis (CF) Sputum and the Effects of Mucoactive Agents

Completed

Conditions: Cystic Fibrosis

First Posted Date: 2008-09-25

Last Posted Date: 2014-03-05

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 38

Registration Number: NCT00758771

Locations: 🇺🇸
UCSF Airway Clinical Research Center, San Francisco, California, United States

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

Completed

Conditions: Chemotherapeutic Agent Toxicity
Cognitive/Functional Effects
Psychosocial Effects of Cancer and Its Treatment
Fatigue
Long-term Effects Secondary to Cancer Therapy in Adults
Breast Cancer
Neurotoxicity

First Posted Date: 2008-09-18

Last Posted Date: 2017-11-24

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 81

Registration Number: NCT00755313

Locations: 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

ECT/Succinylcholine: Biochemical, Serum and Cardiovascular Changes

Terminated

Conditions: Depression

First Posted Date: 2008-09-11

Last Posted Date: 2020-01-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 13

Registration Number: NCT00750906

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer

Phase 2

Terminated

Conditions: Chemotherapeutic Agent Toxicity
Palmar-plantar Erythrodysesthesia
Breast Cancer

Interventions: Drug: Nicotine patch

First Posted Date: 2008-09-11

Last Posted Date: 2020-10-05

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 24

Registration Number: NCT00751101

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

The Polymerase Chain Reaction (PCR) Analysis of Nasal Polyps for Fungal DNA

Not Applicable

Completed

Conditions: Sinusitis
Nasal Polyps

Interventions: Procedure: Nasal swab under endoscopic guidance

First Posted Date: 2008-08-22

Last Posted Date: 2019-12-04

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 260

Registration Number: NCT00739921

Locations: 🇺🇸
University of California, San Francisco, Dept of Otolaryngology-HNS, San Francisco, California, United States

Nutrition and Lifestyle Changes in Patients With Previously Untreated Stage I or Stage II Prostate Cancer

Not Applicable

Completed

Conditions: Prostate Cancer

First Posted Date: 2008-08-22

Last Posted Date: 2012-09-14

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 34

Registration Number: NCT00739791

Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain Metastases

Phase 1

Withdrawn

Conditions: Lung Cancer
Metastatic Cancer

First Posted Date: 2008-08-20

Last Posted Date: 2012-10-04

Lead Sponsor: University of California, San Francisco

Registration Number: NCT00738335

Locations: 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure

Phase 4

Completed

Conditions: HIV Infection

Interventions: Drug: Placebo
Drug: Maraviroc

First Posted Date: 2008-08-14

Last Posted Date: 2020-08-17

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 45

Registration Number: NCT00735072

Locations: 🇺🇸
Stanford University, Stanford, California, United States
🇺🇸
University of California San Francisco - San Francisco General Hospital, San Francisco, California, United States
🇺🇸
Rush University - Stroger Hospital of Cook County, Chicago, Illinois, United States

and more 1 locations

A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas

Phase 1

Completed

Conditions: Glioblastoma
Gliosarcoma
Anaplastic Astrocytoma
Anaplastic Oligodendroglioma

Interventions: Drug: Nanoliposomal CPT-11

First Posted Date: 2008-08-14

Last Posted Date: 2015-01-07

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 34

Registration Number: NCT00734682

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

An Intervention to Reduce Prehospital Delay to Treatment in Acute Coronary Syndrome

Not Applicable

Completed

Conditions: Acute Coronary Syndrome

Interventions: Behavioral: education

First Posted Date: 2008-08-14

Last Posted Date: 2008-08-14

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 3522

Registration Number: NCT00734760

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy